Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Parallel-group, Double-blind, Placebo-controlled Phase III Trial Assessing the Efficacy and Safety of 5-grass Mix SLIT-drops in Adults With Grass Pollen-induced Rhinoconjunctivitis

NCT04881461 is registered in ClinicalTrials.gov with ALK-Abelló A/S as lead sponsor.

NCT NCT04881461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04881461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Parallel-group, Double-blind, Placebo-controlled Phase III Trial Assessing the Efficacy and Safety of 5-grass Mix SLIT-drops in Adults With Grass Pollen-induced Rhinoconjunctivitis
Lead sponsor
ALK-Abelló A/S
Phase
Phase 3
Overall status
Completed
Start date
May 10, 2021
Completion date
September 26, 2023
Enrollment
445 (actual)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

allergy